micro-community-banner
  • Saved

2yr
Preoperative respiratory muscle training combined with aerobic exercise improves respiratory vital capacity and daily life activity following surgical treatment for myasthenia gravis - Journal of Cardiothoracic Surgery

Preoperative respiratory muscle training combined with aerobic exercise improves respiratory vital capacity and daily life activity following surgical treatment for myasthenia gravis - Journal of Cardiothoracic Surgery

Source : https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-023-02283-5

Objective The effects of preoperative respiratory muscle training (RMT) on postoperative complications in patients surgically treated for myasthenia gravis (MG) remain unclear. The present study therefore evaluated the effects of...

Conclusion: RMT and aerobic exercise can have positive effects on postoperative respiratory vital capacity and daily life activity, and would enhance recovery after surgery in MG patients.

  • Saved

2yr
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use - CNS Drugs

Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use - CNS Drugs

Source : https://link.springer.com/article/10.1007/s40263-023-01000-z

Intravenous efgartigimod alfa (also known as efgartigimod alfa-fcab in the USA; Vyvgart®) is the first neonatal Fc receptor antagonist approved in several countries worldwide, including the USA and EU for...

Conclusions/Relevance: The clinical benefits of efgartigimod alfa were durable and reproducible. Furthermore, in an interim analysis of the ongoing open-label phase 3 ADAPT+ extension trial, efgartigimod alfa provided consistent clinically meaningful improvements in patients with gMG. Efgartigimod alfa was generally well tolerated, with most...

  • Saved

2yr
Part 3 Recap of the American Academy of Neurology: AAN 2023 Annual Meeting

The 75th American Academy of Neurology Annual Meeting features sessions, posters, and presentations on the diagnosis and treatment of a full spectrum of neurologic diseases and conditions, including epilepsy, stroke, migraine, movement disorders, diabetic neuropathy, and more.

Hosted at the Boston Convention and Exhibition Center from April 22 to 27, 2023, the six-day meeting has a hybrid format, with sessions held in person and available online.

Click above for a summary of presentations that caught our eye at the conference through Wednesday. Check back soon for our post-conference wrap-up report!

  • Saved

2yr
Part 2 Recap of the American Academy of Neurology: AAN 2023 Annual Meeting

More than 14,000 professionals and exhibitors have descended on Boston for the 75th American Academy of Neurology Annual Meeting.

Hosted at the Boston Convention and Exhibition Center from April 22 to 27, 2023, the six-day meeting has a hybrid format with sessions held in person and available online. The robust program features updates on diagnosing and treating a full spectrum of neurologic conditions, from epilepsy and stroke to migraine and movement disorders.

Click above for a summary of presentations that caught our eye at the conference on Monday and Tuesday. Post-conference recap coming soon!

  • Saved

2yr
Part 1 Recap of the American Academy of Neurology: AAN 2023 Annual Meeting

With thousands of attendees rolling in, the 75th American Academy of Neurology Annual Meeting is taking Boston by storm.

The six-day meeting is being held at the Boston Convention and Exhibition Center from April 22 to 27, 2023, and will be available online. During the meeting, the Academy rings in its 75th anniversary, with a celebration at the Museum of Science. The robust meeting program includes presentations, keynote lectures, abstracts, and posters, all depicting the latest advances in the diagnosis and treatment of a full spectrum of neurologic conditions, from epilepsy and stroke to migraine and movement disorders and everything in between.

Click above for a summary of some presentations that caught our eye at the conference on Saturday and Sunday. Post-conference wrap-up report coming soon!